B-Cell Non-Hodgkin Lymphoma — Trials

B-Cell Non-Hodgkin Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

6,180 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,757
Recruiting: 906
Ph III recruiting: 103
Growth YoY: +6.8%
Industry share: 27%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (954)

clinicaltrialsPublishedShowing 6,151–6,180 of 6,180 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00327314	Non-Myeloablative Allogeneic Transplantation From Unrelated Donors in Multiple Myeloma	unknown	Phase 2	100	Azienda Ospedaliera San Giovanni BattistaOTHER	1	Dec 28, 2006	clinicaltrials
NCT00399867	Simvastatin as Inhibitor of Cell Adhesion Mediated Drug Resistance in Patients With Refractory Multiple Myeloma.	completed	Phase 2	30	Ludwig-Maximilians - University of MunichOTHER	0	Dec 20, 2006	clinicaltrials